Both in Ophthalmic Goods
RxSight vs The Cooper Companies
Over the past year RXST returned −47.1% and COO returned −12.9%; their daily moves had a correlation of 0.29.
RXST −47.1% COO −12.9%Growth of $1, one year, split-adjusted
| Metric | RXST | COO |
|---|---|---|
| Price | $4.59 | $60.83 |
| Market cap | $190.9M | $11.57B |
| Today | −4.38% | −0.77% |
| 1 month | −3.6% | +7.2% |
| 6 months | −36.8% | −0.7% |
| Year to date | −56.0% | −25.8% |
| 1 year | −47.8% | −13.0% |
| Revenue growth (YoY) | +0.3% | +0.6% |
| Gross margin | 76.7% | 66.8% |
| Net margin | −35.9% | 40.6% |
| P/E (TTM) | — | 20.3× |
| Price / sales | 1.5× | 2.7× |
| Net cash | $208.8M | -$2.39B |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 43.3% |
| Short % of float | 10.5% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).